T Cell Dynamics in Mycobacterium Tuberculosis Immunology

Mycobacterium tuberculosis (Mtb) infection elicits a complex orchestration of T cell responses that determine disease outcome. Naïve CD4+ and CD8+ T lymphocytes recognise mycobacterial antigen presented by dendritic cells in lung‐draining lymph nodes and differentiate into effector subsets. Th1 CD4+ cells secrete interferon‐γ to activate infected macrophages, whereas Th17 cells provide IL‐17 for neutrophil recruitment and mucosal defence. Tissue‐resident memory T cells (Trm) localise within the pulmonary parenchyma, offering rapid local protection. Co‐stimulatory receptors, inhibitory checkpoints and cytokine milieu shape the balance between protective immunity and immunopathology. Recent insights into T cell activation kinetics, trafficking receptors and immune exhaustion have informed new host‐directed therapies and improved vaccine design. Understanding the molecular and cellular dynamics of T cells in the lung microenvironment is pivotal to develop next‐generation interventions against tuberculosis.

Research from Nature Portfolio

Recent studies have identified OX40 as a selective marker of recently activated CD4+ T cells within the lung parenchyma during Mtb infection. By tracking these cells using a receptor reporter system, researchers demonstrated that OX40+ CD4+ lymphocytes exhibit superior protective capacity and that short‐term immunotherapy targeting OX40 expands parenchymal‐localised T cells, reduces bacterial burden and extends survival when combined with antibiotics. In parallel, investigations into dendritic cell (DC) modulation revealed that accelerating mucosal DC activation at the time of Mtb exposure can overcome the delay in CD4+ T cell accumulation in the lung. Pulmonary delivery of antigen‐primed DCs or engagement of the CD103+ DC subset via the CD40–CD40L pathway triggers rapid recruitment of vaccine‐induced CD4+ T cells, enhancing early bacterial control and providing a proof of concept for mucosal DC‐targeted strategies to improve vaccine efficacy.

T Cell Dynamics in Mycobacterium Tuberculosis Immunology publication trend

The graph below shows the total number of articles in t cell dynamics in mycobacterium tuberculosis immunology across all publications each year (not limited to Nature Index journals).

Technical terms

OX40: A co‐stimulatory receptor upregulated on recently activated T cells that promotes survival and effector function.

Th17 cell: A subset of CD4+ T cells that secrete IL-17, driving neutrophil recruitment and mucosal defence.

PD-1: An inhibitory checkpoint receptor on T cells that limits effector function to prevent tissue pathology.

Trm (Tissue-resident memory T cell): A non-circulating memory T cell subset residing in peripheral tissues for rapid local response.

Dendritic cell (DC): An antigen-presenting cell that initiates and shapes T cell responses through co-stimulation and cytokine production.

References

1. Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature Communications (2023).
2. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nature Communications (2016).
3. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection. PLOS Pathogens (2017).
4. IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model. Frontiers in Immunology (2024).
5. Tissue resident-like CD4+ T cells secreting IL-17 control Mycobacteria tuberculosis in the human lung. Journal of Clinical Investigation (2021).
6. Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis. Frontiers in Immunology (2019).